Polyphosphoinositide and Phosphoprotein Responses to Muscarinic Receptor Activation in Bovine Adrenal Medulla

  • J. N. Hawthorne
  • A-M. F. Swilem
Part of the Advances in Behavioral Biology book series (ABBI, volume 30)


Bovine adrenal medulla responds to nicotinic stimulation by secreting catecholamines, but simultaneous activation of muscarinic receptors in the perfused gland depresses secretion (10). The calcium influx required for secretion is caused by nicotinic activation (3) but the breakdown of inositol phospholipids considered by Michell (8) to be responsible for mobilization of calcium is produced by muscarinic drugs only. This inositol phospholipid (phosphoinositide) effect was previously thought to be initiated by hydrolysis of phosphatidylinositol but recent work suggests that triphosphoinositide (PtdIns 4,5P2, Fig. 1), a more labile compound associated with plasma membranes and some secretory granules, is the lipid first involved (reviewed in reference 4). A possible sequence of reactions is given in Figure 2.


Muscarinic Receptor Chromaffin Cell Adrenal Medulla Inositol Phospholipid Bovine Chromaffin Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abdel-Latif, A.A., Akhtar, R.A. and Hawthorne, J.N. (1977): Biochem. J. 162: 61–73.Google Scholar
  2. 2.
    Aloyo, V.J., Zwiers, H. and Gispen, W.H. (1982): Prog. Brain Res. 56: 303 315.Google Scholar
  3. 3.
    Fisher, S.K., Holz, R.W. and Agranoff, B.W. (1981): J. Neurochem. 37: 491–497.CrossRefGoogle Scholar
  4. 4.
    Hawthorne, J.N. (1983): Bioscience Reports 3: 887–904.CrossRefGoogle Scholar
  5. 5.
    Hawthorne, J.N., Mohd. Adnan, N. and Lymberopoulos, G. (1980): Biochem. Soc. Trans. 8: 30–32.Google Scholar
  6. 6.
    Hokin, M.R., Benfrey, B.G. and Hokin, L.E. (1958): J. Biol. Chem. 233: 814–817.Google Scholar
  7. 7.
    Kirk, C.J., Creba, J.A., Downes, C.P. and Michell, R.H. (1981): Biochem. Soc. Trans. 9: 377–379.Google Scholar
  8. 8.
    Michell, R.H. (1975): Biochim. Biophys. Acta 415: 81–147.Google Scholar
  9. 9.
    Rhodes, D., Prpic, V., Exton, J.H. and Blackmore, P.F. (1983): J. Biol. Chem. 258: 2770–2773.Google Scholar
  10. 10.
    Swilem, A-M.F., Hawthorne, J.N. and Azila, N. (1983): Biochem. Pharmacology 32: 3873–3874.CrossRefGoogle Scholar
  11. 11.
    Trifaro, J.M. (1969): Mol. Pharmacology 5: 382–393.Google Scholar
  12. 12.
    Van Rooijen, L.A.A., Sequin, E.B. and Agranoff, B.W. (1983): Biochem. Biophys. Res. Commun. 112: 919–926.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • J. N. Hawthorne
    • 1
  • A-M. F. Swilem
    • 1
  1. 1.Department of BiochemistryMedical SchoolNottinghamUK

Personalised recommendations